Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm
NCT00511173
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
102
Enrollment
OTHER
Sponsor class
Conditions
Atrial Fibrillation
Pulmonary Embolism
Deep Vein Thrombosis
Interventions
GENETIC:
Warfarin Dose based on pharmacogenetics
Sponsor
Creighton University